Table 8.
Patient groups | Systolic blood pressure (mmHg)
|
|||||||
---|---|---|---|---|---|---|---|---|
TPH gel
|
FPH gel
|
|||||||
Before application | After application | Percent decrease (%) | P-value | Before application | After application | Percent decrease (%) | P-value | |
Normal patient | 133±5.77 | 107±20.8 | 20 | Not significant | 107±5.77 | 92±2.89 | 14 | Not significant |
Hypertensive patient | 187±20.82 | 147±20.82 | 21.5 | Significant | 167±15.28 | 140±10 | 16 | Significant |
Diabetic patient | 155±7.07 | 140±14.14 | 10 | Not significant | 133±11.55 | 120±10 | 10 | Not significant |
Note: The values were the means ± standard deviation from three parallel measurements.
Abbreviations: TPH, transferosomal papaverine hydrochloride; FPH, free papaverine hydrochloride.